Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 61 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Pharmaphie EVG from Evergem, company number BE0425476840, closed financial year 2025 with a result of € 34,956 after tax. For that financial year Pharmaphie EVG recorded a gross margin of € 132,818 and equity of € 105,896. Compared with financial year 2024, the result moved from € 50,903 to € 34,956. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 4, 2026.
€ 105,896
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 34,956
▼ 31% vs 2024
Profit after tax over the fiscal year.
€ 32,299
▲ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 30,500 paid out
87 % of the profit went to the shareholders, mostly to PHARMAPHIE HOLDING (100 % of the shares). That is where the money ends up.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 90,060
▲ 4% vs 2024
€ 90,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,408
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 81,352
▲ 26% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,564
▼ 13% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 167,507 | € 177,002 | € 148,916 | € 132,818 | ▼ 11% |
| Profit after taxes | € 84,014 | € 85,858 | € 50,903 | € 34,956 | ▼ 31% |
| Equity | € 89,679 | € 90,537 | € 101,440 | € 105,896 | ▲ 4% |
| Total debts | € 147,290 | € 182,273 | € 117,711 | € 123,416 | ▲ 5% |
| Cash | € 63,868 | € 78,762 | € 30,056 | € 32,299 | ▲ 7% |
| Land & buildings | € 24,709 | € 24,553 | € 24,400 | € 24,247 | ▼ 1% |
| Retained profit | € 28,179 | € 29,037 | € 39,940 | € 44,396 | ▲ 11% |
| Dividend | € 86,000 | € 85,000 | € 40,000 | € 30,500 | ▼ 24% |
| Balance sheet total | € 236,969 | € 272,810 | € 219,151 | € 229,312 | ▲ 5% |
| Employees (FTE) | 1 | 1 | 1 | 1 |
Key figures of Pharmaphie EVG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Pharmaphie EVG?
What happened at Pharmaphie EVG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Alexandre Flamant stepped down as director. NBB
- Pharmaphie Holding BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 34,956 (▼ 31% vs 2024). Source: NBB ↗
- Alexandre Flamant became a director. NBB
- Pharmaphie Holding BV became a director. NBB
- New establishment in Gent. KBO
- New establishment in Evergem. KBO
- Start of the company according to the CBE. KBO
In short
From € 84,014 profit in 2022 to € 34,956 profit in 2025.
Paid € 9,374 in corporate taxes since 2022.
Best year ever: 2023, with € 85,858 profit.
On average € 132,800 of value added per employee in 2025.
Management
The stake of PHARMAPHIE HOLDING comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Pharmaphie EVGThe shares are held by PHARMAPHIE HOLDING (99.9%).
Directors
According to the 2025 annual accounts
since 2023 · until 2029
Managing director · represented by Sophie De Brabandere
Also active at: PharmaSpace, Pharmaphie SDW
since 2023 · until 2029
Shareholders
99.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Doornzele Dries 46A
9940 Evergem
Doornzele Dries 46 A
9940 Evergem
Active since 1 April 1984
Hogeheerweg 63
9051 Gent
Active since 1 September 1994
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0425.476.840
- VAT number
- BE 0425.476.840
- Registered office
- Doornzele Dries 46A, 9940 Evergem
- Names & denominations
- Pharmaphie EVG
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 March 1984
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten